ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas
- PMID: 30860119
- DOI: 10.4103/0028-3886.253572
ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas
Abstract
Introduction: Recent advances in the molecular biology of adult diffuse gliomas have brought about a paradigm shift in their diagnostic criteria, as witnessed in the World Health Organization (WHO) 2016 guidelines for central nervous system tumors. It is now mandatory to perform several molecular tests to reach a definitive integrated diagnosis in most of the cases. This comes with additional cost and higher turnaround time, which is not always affordable in developing countries like India. In addition, the non-uniform distribution of advanced research and diagnostic testing centers adds to the difficulty.
Methods: The Indian Society of Neuro-oncology (ISNO) multidisciplinary expert panel consisting of neuropathologists, neurosurgeons, and radiation/medical oncologists convened to prepare the national consensus guidelines for approach to diagnosis of adult diffuse gliomas.
Results: Algorithms for arriving at an integrated diagnosis of adult diffuse gliomas predominantly using immunohistochemistry and with minimum possible additional molecular testing were agreed upon, thus addressing the problems of cost, accessibility, and turnaround time. Mandatory and optional tests were proposed for each case scenario.
Conclusion: This document represents the consensus of the various neuro-oncology disciplines involved in diagnosis and management of patients with adult diffuse gliomas. The article reflects a practical adaptation of the WHO recommendations to suit a resource constrained setup.
Keywords: Consensus guidelines; diagnosis; diffuse glioma; management.
Conflict of interest statement
None
Comment in
-
The Indian Society of Neuro-oncology guidelines: A "personalized" approach to treating adult diffuse gliomas.Neurol India. 2019 Jan-Feb;67(1):183-184. doi: 10.4103/0028-3886.253602. Neurol India. 2019. PMID: 30860120 No abstract available.
Similar articles
-
A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up.J Clin Pathol. 2018 Apr;71(4):323-329. doi: 10.1136/jclinpath-2017-204638. Epub 2017 Aug 11. J Clin Pathol. 2018. PMID: 28801347
-
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.Acta Neuropathol Commun. 2017 May 22;5(1):39. doi: 10.1186/s40478-017-0443-7. Acta Neuropathol Commun. 2017. PMID: 28532485 Free PMC article.
-
Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.Int J Clin Oncol. 2020 Jun;25(6):1004-1009. doi: 10.1007/s10147-020-01628-7. Epub 2020 Feb 4. Int J Clin Oncol. 2020. PMID: 32020379 Review.
-
Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016.Neurol Med Chir (Tokyo). 2017 Dec 15;57(12):658-666. doi: 10.2176/nmc.ra.2017-0071. Epub 2017 Aug 25. Neurol Med Chir (Tokyo). 2017. PMID: 28845038 Free PMC article. Review.
-
WHO 2016 Classification of gliomas.Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150. doi: 10.1111/nan.12432. Neuropathol Appl Neurobiol. 2018. PMID: 28815663 Review.
Cited by
-
Letter regarding Louis et al: The 2021 WHO Classification of Tumors of the Central Nervous System: A summary.Neuro Oncol. 2021 Dec 1;23(12):2120-2121. doi: 10.1093/neuonc/noab190. Neuro Oncol. 2021. PMID: 34596667 Free PMC article. No abstract available.
-
Predicting IDH subtype of grade 4 astrocytoma and glioblastoma from tumor radiomic patterns extracted from multiparametric magnetic resonance images using a machine learning approach.Front Oncol. 2022 Sep 30;12:879376. doi: 10.3389/fonc.2022.879376. eCollection 2022. Front Oncol. 2022. PMID: 36276136 Free PMC article.
-
PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells.Oncol Rep. 2020 Mar;43(3):773-782. doi: 10.3892/or.2020.7472. Epub 2020 Jan 20. Oncol Rep. 2020. PMID: 32020210 Free PMC article.
-
Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?Radiology. 2024 Feb;310(2):e230793. doi: 10.1148/radiol.230793. Radiology. 2024. PMID: 38319162 Free PMC article. Review.
-
Advanced multiparametric MRI-based scoring for isocitrate dehydrogenase mutation prediction of gliomas.Pol J Radiol. 2022 Nov 22;87:e626-e634. doi: 10.5114/pjr.2022.121549. eCollection 2022. Pol J Radiol. 2022. PMID: 36532252 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical